DGCI nod to Covaxin for use in children above 12 years with certain conditions
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech’s EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions. The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech’s Covaxin for … Read more